To uncover whether SREBP1-SCD1 axis determined nutrient-deprived pancreatic cancer cells ferroptosis resistance, we employed CRISPR-Cas9 technology to knockout SREBP1 in pancreatic cancer cells with high efficiency (Figure 4A). This evidence concerns the gene SREBF1 and familial pancreatic carcinoma.